Kawaguchi A - Search Results

1

Phagocytic degradation of chylomicron remnants by fibroblasts from subjects with homozygous familial hypercholesterolaemia.

YU KC, Smith D, Yamamoto A, Kawaguchi A, Harada-Shiba M, Yamamura T, Mamo JC. YU KC, et al. Among authors: kawaguchi a. Clin Sci (Lond). 1997 Feb;92(2):197-203. doi: 10.1042/cs0920197. Clin Sci (Lond). 1997. PMID: 9059322

2

Accumulation of chylomicron remnants in homozygous subjects with familial hypercholesterolaemia.

Mamo JC, Smith D, Yu KC, Kawaguchi A, Harada-Shiba M, Yamamura T, Yamamoto A. Mamo JC, et al. Among authors: kawaguchi a. Eur J Clin Invest. 1998 May;28(5):379-84. doi: 10.1046/j.1365-2362.1998.00284.x. Eur J Clin Invest. 1998. PMID: 9650011

3

Characteristic cardiovascular manifestation in homozygous and heterozygous familial hypercholesterolemia.

Kawaguchi A, Miyatake K, Yutani C, Beppu S, Tsushima M, Yamamura T, Yamamoto A. Kawaguchi A, et al. Am Heart J. 1999 Mar;137(3):410-8. doi: 10.1016/s0002-8703(99)70485-0. Am Heart J. 1999. PMID: 10047619

4

The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy.

Yamamoto A, Harada-Shiba M, Kawaguchi A, Oi K, Kubo H, Sakai S, Mikami Y, Imai T, Ito T, Kato H, Endo M, Sato I, Suzuki Y, Hori H. Yamamoto A, et al. Among authors: kawaguchi a. Atherosclerosis. 2000 Nov;153(1):89-98. doi: 10.1016/s0021-9150(00)00373-7. Atherosclerosis. 2000. PMID: 11058703

5

Apheresis technology for prevention and regression of atherosclerosis.

Yamamoto A, Harada-Shiba M, Kawaguchi A, Tsushima M. Yamamoto A, et al. Among authors: kawaguchi a. Ther Apher. 2001 Aug;5(4):221-5. doi: 10.1046/j.1526-0968.2001.00328.x. Ther Apher. 2001. PMID: 11724504 Review.

6

Clinical features of familial hypercholesterolemia.

Yamamoto A, Kamiya T, Yamamura T, Yokoyama S, Horiguchi Y, Funahashi T, Kawaguchi A, Miyake Y, Beppu S, Ishikawa K, et al. Yamamoto A, et al. Among authors: kawaguchi a. Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I66-74. Arteriosclerosis. 1989. PMID: 2912433

7

Apheresis technology for prevention and regression of atherosclerosis: an overview.

Yamamoto A, Kawaguchi A, Harada-Shiba M, Tsushima M, Kojima S. Yamamoto A, et al. Among authors: kawaguchi a. Ther Apher. 1997 Aug;1(3):233-41. doi: 10.1111/j.1744-9987.1997.tb00144.x. Ther Apher. 1997. PMID: 10225745 Review.

8

Triglyceride and glucose intolerance as a risk factor for coronary heart disease.

Yamamoto A, Yamamura T, Kawaguchi A, Kameda K, Matsuzawa Y. Yamamoto A, et al. Among authors: kawaguchi a. Cardiology. 1991;78(3):185-93. doi: 10.1159/000174785. Cardiology. 1991. PMID: 1868497

9

Assessment of the biocompatibility and long-term effect of LDL-apheresis by dextran sulfate-cellulose column.

Yamamoto A, Kojima S, Shiba-Harada M, Kawaguchi A, Hatanaka K. Yamamoto A, et al. Among authors: kawaguchi a. Artif Organs. 1992 Apr;16(2):177-81. doi: 10.1111/j.1525-1594.1992.tb00290.x. Artif Organs. 1992. PMID: 10078241 No abstract available.

10

Intravascular free tissue factor pathway inhibitor is inversely correlated with HDL cholesterol and postheparin lipoprotein lipase but proportional to apolipoprotein A-II.

Kawaguchi A, Miyao Y, Noguchi T, Nonogi H, Yamagishi M, Miyatake K, Kamikubo Y, Kumeda K, Tsushima M, Yamamoto A, Kato H. Kawaguchi A, et al. Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):251-8. doi: 10.1161/01.atv.20.1.251. Arterioscler Thromb Vasc Biol. 2000. PMID: 10634826

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,022 results

Search Page

Filters